Showing 850 – 860 of 1303 results
-
Actinium Pharmaceuticals, Inc. Initiation
William Blair & Company initiated research coverage of Actinium Pharmaceuticals, Inc. (ATNM $0.21). Actinium is leading biotech company that specializes in radiopharmaceuticals.
-
Billcom Holdings Inc Initiation
William Blair & Company initiated research coverage of Bill.com Holdings, Inc. (BILL $38.70), a provider of financial business process automation software for the small to midsize business (SMB) market.
-
TTEC Holdings Inc Initiation
William Blair & Company initiated research coverage of TTEC Holdings, Inc. (TTEC $37.85), a global technology and services company that designs and implements customer experience (CX) management solutions for companies in the Global 1000.
-
Xenon Pharmaceuticals Inc Initiation
William Blair & Company initiated research coverage of Xenon Pharmaceuticals Inc. (XENE $13.49), a clinical-stage biopharmaceutical company focused on developing therapies for neurological disorders including rare pediatric epileptic encephalopathies and generalized epilepsies.
-
Cardlytics Inc Initiation
William Blair & Company initiated research coverage of Cardlytics, Inc. (CDLX $24.59), a card-linked marketing platform powered by purchase data from more than 2,000 financial institution partners.
-
Thunder Bridge Acquisition Ltd Initiation
William Blair & Company initiated research coverage of Thunder Bridge Acquisition, Ltd. a.k.a. REPAY (TBRG $10.39). Based in Atlanta, Repay is an omnichannel integrated payment technology provider primarily focused on the auto finance, personal loan, consumer receivable management, healthcare receivables management, and financial institution markets.
-
Tufin Software Technologies Ltd. Initiation
William Blair & Company initiated research coverage of Tufin Software Technologies Ltd. (TUFN $21.42), which provides a centralized security management layer that analyzes, defines, and implements IT security policies.
-
Birkenstock Holding plc Initiation
William Blair initiated research coverage of Birkenstock Holding plc (BIRK $40.20), a global brand anchored by a broad array of footwear featuring the company’s proprietary contoured footbed.
-
Vertex Pharmaceuticals Incorporated Initiation
William Blair initiated research coverage of Vertex Pharmaceuticals Incorporated (VRTX $332.63), a biopharma company focused on the development and commercialization of transformative specialty medicines for the treatment of cystic fibrosis (CF) and other rare genetic diseases.
-
Cross Country Healthcare Inc Initiation
William Blair initiated research coverage of Cross Country Healthcare, Inc. (CCRN $26.44), a leading provider of healthcare staffing and talent solutions.